Eisai CO Ltd ADR (OP: ESALY )

79.96 USD +0.31 (+0.39%)

Official Closing Price Updated: 3:45 PM EDT, Oct 26, 2020 Add to My Watchlist

Price and Volume

Volume	1,172
Open	79.20
Bid (Size)	N/A (0)
Ask (Size)	N/A (0)
Prev. Close	79.65
Today's Range	79.20 - 80.34
52wk Range	54.00 - 92.54
Shares Outstanding	286,338,549
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News

Eisai and Cogstate Expand Agreement for Global Development and Commercialization of Digital Cognitive Assessment Technologies

Today 11:52 EDT

Eisai: Supplementary New Drug Applications for Anti-Epileptic Drug Fycompa as Monotherapy for Partial-Onset Seizures

October 16, 2020

Performance

YTD	+6.40%	+6.40%
1 Month	-11.20%	-11.20%
3 Month	-3.25%	-3.25%
6 Month	+20.06%	+20.06%
1 Year	+5.77%	+5.77%

More News

The University of Tokyo and Eisai Announce Research Collaboration for the Development and Drug Discovery of Targeted Protein Degradation Technology

October 08, 2020

Eisai: Joint Development Agreement Aiming for Drug Discovery for COVID-19 Utilizing Eritoran and E6011 Concluded

October 06, 2020

Eisai and Seikagaku Enter into Agreement for the Marketing Alliance of SI-613, a Treatment of Osteoarthritis, in South Korea

September 30, 2020

Eisai: Jyseleca (Filgotinib) Approved in Japan for Rheumatoid Arthritis

September 28, 2020

Eisai Receives Positive Opinion from EMA's CHMP on Use of Antiepileptic Agent Fycompa in Pediatric Patients

September 23, 2020

Eisai and Merck Present First-Time Data From Two Studies Evaluating KEYTRUDA (pembrolizumab) Plus LENVIMA (lenvatinib) in Seven Different Tumor Types at ESMO Virtual Congress 2020

September 23, 2020

Eisai Presents Latest Data of Phase I Clinical Trial on Liposomal Formulation of Anti-Cancer Agent Halaven (Eribulin) at ESMO Virtual Congress 2020

September 18, 2020

Eisai Establishes Pharma Sales Subsidiary in Vietnam

September 17, 2020

Eisai to Present Abstracts on Oncology Products and Pipeline at ESMO Virtual Congress 2020

September 11, 2020

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.